How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
What is the current share price of Recursion Pharmaceuticals (RXRX)? Recursion Pharmaceuticals's (RXRX) current share price is $3.00. This constitutes a price movement of 9.38% when compared to the ...
In 1990 newly independent Namibia became one of the world’s first nations to write environmental protection into its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results